» Articles » PMID: 19009140

Vulnerability and Non-adherence to Antiretroviral Therapy Among HIV Patients, Minas Gerais State, Brazil

Overview
Specialty Public Health
Date 2008 Nov 15
PMID 19009140
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to describe vulnerability profiles and to verify their association with non-adherence to antiretroviral therapy (ART) among 295 HIV-patients receiving their first prescription in two public-referral centers in Minas Gerais States, Brazil. The cumulative incidence of non-adherence was 36.9%. Three pure vulnerability profiles (lower, medium and higher) were identified based on the Grade of Membership method (GoM). Pure type patients of the "higher vulnerability" profile had, when compared to the overall sample, an increased probability of being younger, not understanding the need of ART, having a personal reason to be HIV-tested, not disclosing their HIV status, having more than one (non-regular) sexual partner, reporting use of alcohol, tobacco and illicit drugs, and having sex among men. Non-adherence to ART was statistically associated (p < 0.001) with this profile. Also, the heterogeneity of the sample was found to be high, since over 40% were mixed type. The implications are that health staff should be trained to develop strategies for incorporating risk-reduction interventions, bearing in mind the three dimensions of vulnerability and the diversity of those patients initiating antiretroviral therapy.

Citing Articles

Adherence to antiretroviral therapy in people living with HIV with moderate or severe mental disorder.

Arashiro P, Guadeluppe Maciel C, Freitas F, Serrano Ramires Koch G, Pereira da Cunha J, Stolf A Sci Rep. 2023; 13(1):3569.

PMID: 36864110 PMC: 9980869. DOI: 10.1038/s41598-023-30451-z.


The Impact of Formal and Informal Institutions on ART Drug Adherence.

Kumsa D, Tucho G J Int Assoc Provid AIDS Care. 2019; 18:2325958219845419.

PMID: 31109220 PMC: 6748520. DOI: 10.1177/2325958219845419.


Quality of life, anxiety and depression in patients with HIV/AIDS who present poor adherence to antiretroviral therapy: a cross-sectional study in Salvador, Brazil.

Betancur M, Lins L, de Oliveira I, Brites C Braz J Infect Dis. 2017; 21(5):507-514.

PMID: 28535397 PMC: 9425484. DOI: 10.1016/j.bjid.2017.04.004.


The influence of depressive symptoms and substance use on adherence to antiretroviral therapy. A cross-sectional prevalence study.

Tufano C, Abrantes do Amaral R, Cardoso L, Malbergier A Sao Paulo Med J. 2014; 133(3):179-86.

PMID: 25250800 PMC: 10876366. DOI: 10.1590/1516-3180.2013.7450010.


Association between smoking, crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, Brazil.

Batista J, de Albuquerque M, Santos M, Miranda-Filho D, Lacerda H, Maruza M Rev Inst Med Trop Sao Paulo. 2014; 56(2):127-32.

PMID: 24626414 PMC: 4085845. DOI: 10.1590/S0036-46652014000200007.